Amalgamated Bank Day One Biopharmaceuticals, Inc. Transaction History
Amalgamated Bank
- $13.6 Billion
- Q3 2025
A detailed history of Amalgamated Bank transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 1,782 shares of DAWN stock, worth $18,461. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,782
Previous 1,782
-0.0%
Holding current value
$18,461
Previous $11,000
9.09%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding DAWN
# of Institutions
178Shares Held
70.4MCall Options Held
59.6KPut Options Held
23.5K-
Atlas Venture Life Science Advisors, LLC6.43MShares$66.6 Million9.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.18MShares$64 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$47 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA4.1MShares$42.5 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.72MShares$38.6 Million0.56% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $761M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...